Hepatitis B X-interacting protein (HBXIP) is a novel oncoprotein and plays a key role in the development of breast cancer. However, its mechanisms of action are poorly understood. Lin28B functions as an oncogene in a variety of human cancers. In our study, we report that HBXIP acts with its partner Lin28B to contribute to carcinogenesis. Our data showed that the expression levels of HBXIP were significantly positively correlated with those of Lin28B in clinical breast cancer tissues. Then, we found that HBXIP was able to upregulate Lin28B in breast cancer MCF-7 cells. Chromatin immunoprecipitation assay (ChIP) and electrophoretic mobility shift assay (EMSA) revealed that HBXIP occupied the promoter region (21199/-1073 nt) of Lin28B. Importantly, co-immunoprecipitation (Co-IP) and GST pull-down assay validated that HBXIP directly bound to the TATA-binding protein (TBP), a basal subunit of transcription factor TF II D complex. In addition, we discovered that Lin28B could block the downregulation of HBXIP via suppressing miR-520b which directly targeted HBXIP mRNA in the cells. In function, we demonstrated that HBXIP enhanced the proliferation of breast cancer cells through Lin28B in vitro and in vivo. Thus, we conclude that the oncoprotein HBXIP as a co-activator of TF II D transactivates Lin28B promoter via directly binding to TBP to upregulate the expression of Lin28B in promotion of proliferation of breast cancer cells, in which Lin28B maintains the high level of HBXIP through suppressing miR-520b in a feedback manner. Therapeutically, HBXIP may serve as a target of breast cancer.Hepatitis B X-interacting protein (HBXIP), a conserved 18KDa protein, is originally identified by its interaction with the hepatitis B virus X protein (HBx) and negatively regulates the activity of HBx and alters the replicative life cycle of the virus. 1 Expression of HBXIP mRNA occurs in nearly all tissues not limited to liver and is also in mice and other rodents. 2 The sequences of the HBXIP gene, containing a putative leucine zipper motif and two consensus phosphorylation sites for protein kinase C and casein kinase II, are well conserved among mammalian species. 1 HBXIP can regulate the duplication of centrosome and HBXIP-deficient Hela cells succumb eventually to apoptosis. In addition, a mouse model of liver regeneration experiment shows HBXIP is a critical regulator of hepatocyte cell growth in vivo. 3 Studies also report that HBXIP functions as a cofactor with survivin through forming a complex to suppress apoptosis. 2 Importantly, our group shows that HBXIP plays crucial roles in the development of breast cancer, serving as a key oncoprotein in cancer. [4][5][6][7] Recently, we show that HBXIP promotes the breast cancer cell growth by upregulating S100A4. 7 However, the mechanism by which HBXIP enhances the proliferation of breast cancer cells remains poorly understood.Lin28B, a homolog of Lin28, originally identified in hepatocellular carcinoma conserves a cold shock domain and a pair of CCHC zinc finger domains. 8 Lin28B i...